Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series
- PMID: 33456087
- PMCID: PMC7792539
- DOI: 10.5114/reum.2020.102010
Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series
Abstract
Systemic juvenile idiopathic arthritis (sJIA) is a heterogeneous category of arthritis that frequently leads to disability and severe complications. The clinical cause of sJIA is very variable, which results in difficulties of disease recognition. In this literature review based on case series we outline the main challenges in diagnostic of sJIA and macrophage activation syndrome (MAS). Using the 2016 criteria for MAS diagnostic allowed to consider MAS in the diagnostically challenging cases, that confirms their sensitivity in pediatric patients. The reviewed literature showed last updates for the improvement of classification, diagnostic of sJIA and its complication. The modification of JIA criteria, initiated by Paediatric Rheumatology International Trials Organisation, will allow to improve detection and treatment of JIA. The presentation of this clinical cases and the discussion may be useful for understanding the disease cause and will help to differentiate sJIA and MAS from other disorders, and to improve treatment outcomes.
Keywords: diagnosis; macrophage activation syndrome; systemic juvenile idiopathic arthritis.
Copyright: © 2020 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?Clin Rheumatol. 2024 Jan;43(1):415-421. doi: 10.1007/s10067-023-06828-w. Epub 2023 Nov 28. Clin Rheumatol. 2024. PMID: 38012469
-
Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.Arthritis Rheumatol. 2022 Jul;74(7):1271-1283. doi: 10.1002/art.42099. Epub 2022 May 31. Arthritis Rheumatol. 2022. PMID: 35189047 Free PMC article.
-
Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study.Medicina (Kaunas). 2023 Apr 20;59(4):798. doi: 10.3390/medicina59040798. Medicina (Kaunas). 2023. PMID: 37109756 Free PMC article.
-
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Arthritis Rheumatol. 2016 Mar;68(3):566-76. doi: 10.1002/art.39332. Epub 2016 Feb 9. Arthritis Rheumatol. 2016. PMID: 26314788
-
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Ann Rheum Dis. 2016 Mar;75(3):481-9. doi: 10.1136/annrheumdis-2015-208982. Ann Rheum Dis. 2016. PMID: 26865703
Cited by
-
Clinical and autoantibody phenotypes of juvenile dermatomyositis.Reumatologia. 2022;60(4):281-291. doi: 10.5114/reum.2022.119045. Epub 2022 Sep 8. Reumatologia. 2022. PMID: 36186835 Free PMC article.
-
Overlapping clinical features of systemic juvenile idiopathic arthritis and SARS-CoV-2-related multisystem inflammatory syndrome in children.Reumatologia. 2023;61(1):63-70. doi: 10.5114/reum/161185. Epub 2023 Mar 8. Reumatologia. 2023. PMID: 36998579 Free PMC article.
-
Attempts to identify the molecular cause of autoinflammatory recurrent fever.Reumatologia. 2024;62(5):381-388. doi: 10.5114/reum/193903. Epub 2024 Nov 8. Reumatologia. 2024. PMID: 39677881 Free PMC article. Review.
-
Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis.Int J Mol Sci. 2022 Apr 12;23(8):4268. doi: 10.3390/ijms23084268. Int J Mol Sci. 2022. PMID: 35457086 Free PMC article. Review.
-
Clinical outcomes of tocilizumab therapy in polyarticular and systemic juvenile idiopathic arthritis: a single-center analysis (2018-2022).Rheumatol Int. 2024 Dec;44(12):2949-2959. doi: 10.1007/s00296-024-05711-4. Epub 2024 Sep 23. Rheumatol Int. 2024. PMID: 39311914 Free PMC article.
References
-
- Cassidy JT, Petty RE. Chronic arthritis in childhood. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB, editors. Textbook of Pediatric Rheumatology. Philadelphia: Saunders Elesvier; 2005. pp. 206–300.
-
- Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J Rheumatol. 2004;31:390–392. - PubMed
Publication types
LinkOut - more resources
Full Text Sources